Natural product-based therapy for Cerebral Ischemia: Psammaplin A (PsA), isolated from marine sponges, increases cerebral blood flow and inhibits cerebral ischemia via up regulation of its target gene, 10/February/2016, 22.34

Natural product-based therapy for Cerebral Ischemia: Psammaplin A (PsA), isolated from marine sponges, increases cerebral blood flow and inhibits cerebral ischemia via up regulation of its target gene, 10/February/2016, 22.34

Natural product-based therapy for Cerebral Ischemia: Psammaplin A (PsA), isolated from marine sponges, increases cerebral blood flow and inhibits cerebral ischemia via up regulation of its target gene, 10/February/2016, 22.34 150 150

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

CitationBoominathan, Natural product-based therapy for Cerebral Ischemia: Psammaplin A (PsA), isolated from marine sponges,  increases  cerebral blood flow and inhibits cerebral ischemia via up regulation of its target gene, 10/February/2016, 22.34, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Significance: This study suggests that Psammaplin A, by increasing the expression of its target gene, it may preserve cerebral blood flow.  Thereby, it may inhibit the development of cerebral ischemiaThus, this study suggests that pharmacological formulations encompassing Psammaplin A or its analogues may be used to inhibit cerebral ischemia.

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Undisclosed information: How Psammaplin A preserves cerebral blood flow and inhibits cerebral ischemia

Amount: $500*